Cisa home laiv study - contributing site EO 14398
Active Awarded
- Contract number
- 75D30126F00003
- Awardee
-
Boston Medical Center Corporation UEI JZ8RQC4EMDZ5
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $784,899
Award facts
- Opportunity
-
- 75D30126R73524 Solicitation number
- Contract value 98% obligated
-
- $784,899.00 Current, with exercised options
- $803,870.00 Potential, with all options
- Completion date 3% complete
- Current and potential, with all options
- NAICS code
- 622110 General Medical and Surgical Hospitals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 8 offers Multiple Award, Fair Opportunity
- Pricing
- Time and Materials
- Place of performance
- Roxbury, MA 02118, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The Centers for Disease Control and Prevention Pittsburgh issued a delivery order to Boston Medical Center Corporation on September 25, 2026, under the Clinical Immunization Safety Assessment (CISA) IDIQ, with a ceiling value of $803,870 for a contributing site in the HOME LAIV Study supporting Executive Order 14398.
The CISA IDIQ, established through September 2028, supports clinical immunization safety assessment services across federal agencies. Place of performance is Roxbury, MA. The order carries an ultimate completion date of September 27, 2029 and is priced on a time-and-materials basis with no set-aside applied. Boston Medical Center Corporation is a tax-exempt academic medical center and safety-net hospital based in Boston providing specialized clinical services and biomedical research support to federal agencies. The awardee performs service work with internal staff.
Quick answers
Who was awarded contract 75D30126F00003?
75D30126F00003 was awarded to Boston Medical Center Corporation by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 25, 2026.
How much is contract 75D30126F00003 worth?
The government has obligated $784,899 on 75D30126F00003. Its potential value, with all options, is $803,870.
Is contract 75D30126F00003 an order under another contract?
Yes. 75D30126F00003 is a delivery order under 75D30123D17920, an indefinite delivery contract, on Clinical Immunization Safety Assessment 2023 - 2028 (CISA).
Was contract 75D30126F00003 competed?
The extent of competition for 75D30126F00003 was full and open competition. The government received 8 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award